Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Among its various types, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases. Over the past two decades, targeted therapies have transformed cancer treatment, offering more effective and less toxic alternatives compared to traditional chemotherapy. One such groundbreaking drug is...